[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Editor's Correspondence
November 13, 2006

Clopidogrel in Patients With Acute Coronary Syndromes: Learning From Clinical Practice

Arch Intern Med. 2006;166(20):2292-2293. doi:10.1001/archinte.166.20.2292-b

Tricoci et al1 examined over 60 000 patients with high-risk non–ST-segment elevation acute coronary syndrome (NSTE ACS) in the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA [American College of Cardiology/American Heart Association] Guidelines) Quality Improvement Initiative. They found that only slightly over half received clopidogrel at discharge and the majority who did not undergo catheterization did not receive clopidogrel. The patterns and trends for receiving clopidogrel were similar for patients who received care by cardiologists or noncardiologists, a fact that might seem surprising in light of published guidelines.2

First Page Preview View Large
First page PDF preview
First page PDF preview